Skip to content

Clinical Observation on Effect of Yanghe Decoction inTreating Patients with non-systemic involved Sjogren Syndrome(NSI-SS)

Clinical Observation on Effect of Yanghe Decoction inTreating Patients with non-systemic involved Sjogren Syndrome(NSI-SS)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-17013453
Enrollment
Unknown
Registered
2017-11-20
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren Syndrome

Interventions

test group:Yanghe Decoction
Control group:HCQs

Sponsors

First Affiliated Hospital, Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 80 patients diagnosed according to the 2002 international classification criteria for Sjogren's syndrome were all outpatients and inpatients with rheumatism and immunology in our hospital. Choices: (1) Female patients, ages 20-65 years; (2) No systemic involvement, such as pericardial effusion, interstitial lung disease, autoimmune liver disease, primary sclerosing cholangitis, tubular acidosis and atrophy Gastritis, etc.; (3) did not use glucocorticoids, HCQs and other drugs within 1 month before enrollment.

Exclusion criteria

Exclusion criteria: (1)allergic constitution; (2) fundus examination has a lack of vision and macular degeneration; (3) accompanied by viral hepatitis, alcoholic liver disease, fatty liver and drug-induced liver disease.

Design outcomes

Primary

MeasureTime frame
Saliva flow;Schirmer test;serum ?-globulin;

Countries

China

Contacts

Public ContactTONG Ying

First Affiliated Hospital, Heilongjiang University of Chinese Medicine

tymm0451@126.com+86 18686780398

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026